Pharma
Diathrive Health users will have access to Mark Cuban Cost Plus Drug Company's lower-cost diabetes medication and testing supplies.
The Digital Medicine Society partnered with digital health and pharma players like the FDA, Janssen, GSK, Medable and THREAD to build a toolkit aimed at improving diversity in digital research.
It will be used to invest in specialised healthcare logistics and financing, among other plans.
OncoPower users will have access to Cost Plus Drugs' prescriptions through the partners' Medication Savings Suite.
The funds will help the company grow its platform and scale partnerships with life science companies and healthcare systems.
They seek to identify digital predictive biomarkers of narcolepsy and excessive daytime sleeping.
The grocery chain's healthcare division also announced its first trial, a collaboration with Persephone Biosciences.
RxPass, which will be available to Prime members, will offer generic drugs for common conditions like high blood pressure and anxiety.
The U.K.-based company will form an advanced clinical trials division offering digital health solutions for each phase of the development process.
Cuban tells MobiHealthNews that MCCPDC is working on adding partnerships with PBMs that "share our mission of cost-plus pricing, transparency and no rebates."